@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com 5 years ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
@xconomy.com 5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@venturebeat.com 6 years ago
Relay Therapeutics Secures $63 Million in Series B Financing
@venturebeat.com 8 years ago
Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence